Searched for
MYCOPHENOLATE MOFETIL
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspension- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 26% in 1 year
- Ignore noise on the street, stick to basics: 5 stocks from different sectors with an upside potential of up to 38%The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...10 Oct, 2024, 05.00 AM IST
- For moderate risk takers: 5 midcap stocks from different sectors with potential upside of up to 36%Unlike last quarter of 2023, when nifty and sensex used to witness correction and mid-cap index was able move higher. Since the start of 20...15 Feb, 2024, 02.06 PM IST
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...04 Jan, 2024, 02.09 PM IST
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside scope of over 20%As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....07 Nov, 2023, 01.02 PM IST
- Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral suspensionStrides Pharma Science Ltd on Wednesday said its wholly-owned arm, Strides Pharma Global Pte. Ltd, Singapore, has received approval from th...30 Aug, 2023, 01.40 PM IST
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...10 May, 2023, 01.13 PM IST
- Should you stick to largecaps amid volatile Nifty? These 4 stocks have up to 30% upside scopeAs volatility increases, the focus in the market is shifting to stocks which are considered as relatively defensive. These stocks tend to f...09 Feb, 2023, 05.54 PM IST
- A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...17 Jan, 2023, 11.25 AM IST
- Panacea Biotec sells domestic formulation assets to Mankind Pharma for Rs 1,908 crorePanacea said it expects to complete the transaction by the end of this year.01 Feb, 2022, 06.55 PM IST
- Roche Pharma India expands partnership with Cipla for key oncology medicinesRoche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...18 Jun, 2020, 11.45 AM IST
- Buy Alkem Labs, target price Rs 2,897: Anand RathiAlkem’s Q4 FY20 sales growth is likely to be up 10 per cent to Rs 20 billion.24 Apr, 2020, 02.08 PM IST
- Zydus Cadila gets USFDA nod for Mycophenolate MofetilThe approval is for Mycophenolate Mofetil injection of strength 500mg/vial, the company said in a BSE filing.02 Sep, 2017, 05.38 PM IST
- Jubilant Life Sciences shares climb nearly 4 per centShares of Jubilant Life surged nearly 4% after IT received final approvals from USFDA for sale of generic anti-hypertensive Valsartan table...06 Jan, 2015, 06.48 PM IST
- Global woes hit Sensex, cracks over 800 points; top ten stocks in focusThe Nifty was at 8114.55 down 263.85 points. It touched a high of 8327.85 and a low of 8114.55 in trade today.06 Jan, 2015, 03.26 PM IST
- Ten stocks in focus in Tuesday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.06 Jan, 2015, 08.06 AM IST
- Jubilant Life Sciences gets FDA nod for Mycophenolate Mofetil & RizatriptanThe approvals are for Mycophenolate Mofetil in the strengths of 250 mg capsules and 500 mg tablets and Rizatriptan tablets in strengths of ...05 Jan, 2015, 07.09 PM IST
- Mylan sells stake in Concord BiotechWorld’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...08 Dec, 2009, 12.08 AM IST
Load More
